CBS 2019
CBSMD教育中心
中 文

动脉粥样硬化性心血管疾病

Abstract

Recommended Article

Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular DiseaseA Prespecified Analysis From the FOURIER Trial Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes The Science Underlying COVID-19: Implications for the Cardiovascular System Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Coronary calcium as a predictor of coronary events in four racial or ethnic groups

Clinical Trial2019 Mar; 4(3): 273–286.

JOURNAL:JAMA Cardiol. Article Link

Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial

JS Hochman, HR Reynolds, S Bangalore et al. Keywords: sex difference; ischemia; plaque burden

FULL TEXT PDF